Zyanya Rizzo, PharmD Candidate
Articles by Zyanya Rizzo, PharmD Candidate

From ECHELON-3 to Clinical Practice: Newly Approved Brentuximab Vedotin With Lenalidomide and Rituximab for R/R DLBCL
ByAmi Ali, PharmD, BCOP,Melissa Martinez, PharmD ,Martina Nasralla, PharmD Candidate,Zyanya Rizzo, PharmD Candidate,Lamya Al-Saleh, PharmD, RPh BV-R2 combination shows survival benefit across high-risk subgroups.

Ph-like ALL may be predominantly prevalent in Hispanic and Latino populations.